#In Situ Hybridization (ISH) Market Research

[prajwal-agale001]

Slide Stainers Market Trends and Forecast: Key Drivers and Challenges to 2030

According to the latest publication from Meticulous Research®, the global slide stainers market is on a growth trajectory, with projections estimating it will reach $5.53 billion by 2030, achieving a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period. This growth is largely fueled by the increasing geriatric population, the rising burden of chronic diseases, and advancements in slide staining technology. Additional drivers include the rising demand for personalized treatments, escalating healthcare expenditures, and a surge in automation within diagnostics and clinical research.

Emerging economies and the growing need for automated slide staining and diagnostic systems are poised to present significant growth opportunities. However, the high cost of slide stainer systems and concerns regarding automation and the shortage of skilled professionals are potential constraints on market expansion.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5643

Key Players:

Prominent players in the slide stainers market include Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Abcam plc. (U.K.), Siemens Healthineers (Germany), General Data Company, Inc. (U.S.), Biocare Medical, LLC. (U.S.), BioGenex (U.S.), PHC Holdings Corporation (Japan), and Hardy Diagnostics (U.S.).

Market Segmentation and Insights:

The slide stainers market is segmented by product type, technique, application, end user, and geography.

Product Type: The market is divided into reagents and kits, equipment, and accessories and consumables. In 2024, the reagents and kits segment is expected to hold the largest market share, driven by the growing clinical research and development activities and increased adoption of laboratory automation solutions. This segment includes various reagents for tissue fixation, processing, and staining.

Technique: The market is segmented into Hematoxylin and Eosin (H&E), in-situ hybridization (ISH), immunohistochemistry (IHC), hematology, cytology, and microbiology. The H&E staining technique is anticipated to dominate due to its widespread use in examining tissue and cellular structures, crucial for diagnosing cancer, infectious diseases, and chronic conditions. Its broad application and benefits, such as detailed identification of tissue features, contribute to its significant market share.

End User: The market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs). Hospitals and diagnostic centers are projected to account for the largest share in 2024. Automated slide stainers are increasingly utilized in these settings for their efficiency in preparing slides for microscopic examination, driven by rising patient volumes and the demand for automation.

Geography: The market analysis covers North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. North America is expected to lead the market, with the U.S. being the largest market shareholder due to its advanced healthcare infrastructure and the presence of major market players. Europe and Asia-Pacific are also significant contributors to market growth.

Future Outlook:

The slide stainers market is poised for substantial growth, driven by technological innovations and increasing healthcare demands. While challenges such as high costs and automation concerns remain, the market is expected to benefit from the rising adoption of automated systems and ongoing advancements in staining technologies.

Read Full Report:- https://www.meticulousresearch.com/product/slide-stainers-market-5643?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=10-09-2024

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[marketingreportz]

Companion Diagnostics Market - Forecast(2024 - 2030)

 Companion Diagnostic Market Overview:

The Harvard University, while addressing the risk associated with reactions of new drugs prescription, has stated some overwhelming facts. According to their findings, even properly prescribed drugs causes about 1.9 million hospitalizations a year and about 128,000 people die from drugs prescribed to them.[1] Such epidemic condition is being tailgated by the need of safe and effective and specific use of the drug. Owing to such demands, companion diagnostic drug market is poised for exponential growth. Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients and is crucial for myriad of cancer and other therapies. Riding on the back of economic burden of global healthcare and with abundant potential to restrict the liability, companion diagnostic market size is estimated to be $2,950 million as of 2018.

Inquiry Before Buying

Companion Diagnostic Market Outlook:

Companion diagnostic (CDx) is a diagnostic test used as an associate to a therapeutic drug to regulate its applicability to an individual person. It involves multiple monitoring methods including immunohistochemistry (IHC), polymerase chain Reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), and gene sequencing. The companion diagnostics uses technologies such as molecular biology technique, drug and diagnostic technology, and oncology therapy for the treatment of colorectal cancer, breast cancer, and other chronic diseases.

 An acute analysis of the region-wise companion diagnostic market share concluded with reckoning North America as the most lucrative market for CDx. This region with cutting-edge healthcare technology in the United States and Canada generates 41% of the global companion diagnostic market demand for alarming need for cancer diagnosis and treatment. According to the American Cancer Society, prostate cancer is the most common cancer among males (19%), followed by lung (14%) and colorectal (9%) cancers and among females, breast (30%), lung (12%), and colorectal (8%) cancers are the most common. Increasing instances of cancer along with neurological disorders, infectious diseases, Hepatitis A is augmenting the North American companion diagnostic market.

Companion diagnostic market with abundant potential as an effective tool for personalized medicine has found a tremendous scope of application in pharmaceuticals, laboratories, research institutes and hospitals. Hospital as an end-user industry is the leading segment progressing with an application CAGR of 12.5% going through 2025. Hospitalized patients account for a total of 2.74 million serious adverse drug reactions. Each CDx test is specifically designed to be corresponding with an exact drug. Such tests can also save significant hospital expenditure by targeting specific patients with the most effective therapy.

Request Sample

 Companion Diagnostic Market Trends and Growth Drivers:

·         The necessity for personalized therapeutics for the cumulative geriatrics population and the increasing figure of diagnostics centers in both the developed and developing economies is predominant to determine profits in the global companion diagnostics market.

·         FDA had issued "Guidance for Industry: In Vitro Companion Diagnostic Devices," to assist syndicates recognize the necessity for companion diagnostics at an initial stage in the drug development procedure and to strategize for co-development of the drug and companion diagnostic test.

 On July 15, 2016, FDA introduced the draft regulation, "Principles for Co-development of an In Vitro Companion Diagnostic Device with a Therapeutic Product." This guidance text is envisioned to be a practical guide to support therapeutic product promoters and IVD sponsors in evolving a therapeutic product and an associated IVD companion diagnostic. The scientific progressions in the in-situ hybridization and automated silver-enhanced in-situ hybridization (SISH) for the monitoring of genes is trending in the global companion diagnostics market.

Schedule a Call

 Companion Diagnostic Market Players Perspective:

Some of the key players influencing the global market are:-  Abbott Laboratories, Agilent Technologies, biomerieux, Bio-Genex Laboratories, Danaher Corporation, GE Healthcare, Myriad Genetics, Inc., QIAGEN N.V., R-Biopharm AG, and Roche Diagnostics.

In April 2017, Abbott acquired Alere for a new price of about $5.3 billion. Alere is the global leader in point of care diagnostics focused on the areas of infectious disease, molecular, cardiometabolic and toxicology. The collective business will offer the biggest point of care menu of infectious disease, molecular, cardiometabolic and toxicology testing. Abbott's platforms will be expanded to comprise benchtop and rapid strip tests.

Buy Now

 Companion Diagnostic Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the companion diagnostic market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various diagnostics in companion diagnostic market, and their specific advantages.

[wellnessweb]

Strategic Partnerships and Collaborations in the Molecular Diagnostics Market

The Molecular Diagnostics Market valued at USD 14.60 billion in 2023 and is estimated to reach USD 29.67 billion by 2032 with a CAGR of 8.22% over the forecast period 2024-2032.The molecular diagnostics market has rapidly evolved into a cornerstone of modern healthcare, where precision meets innovation.

As technology advances, molecular diagnostics harnesses the power of genetic insights to revolutionize disease detection and treatment. From identifying genetic mutations that predispose individuals to certain cancers to enabling targeted therapies based on personalized genetic profiles, this field continues to expand its impact. With its ability to deliver rapid, accurate, and actionable results, molecular diagnostics not only enhances clinical decision-making but also drives forward the era of personalized medicine, promising better outcomes and improved quality of life for patients worldwide.

The Molecular Diagnostics Market  research report offers in-depth information on anticipated trends, market drivers, development opportunities, and market restraints that may have an impact on the sector's market dynamics. Along with product, application, and competition research, it also includes in-depth analyses of several market segments. Significant actors, important alliances, mergers, and acquisitions are all examined in the study, along with current innovation and corporate strategy. This market study includes recent developments, untapped markets, new products, and investments. This report provides in-depth data on potential emerging areas as well as a market penetration analysis of well-established categories.

Get Sample Copy Of This Report @ https://www.snsinsider.com/sample-request/2806

Market Segmentation

By Product

Instruments

Reagents

Others

By Technology

Polymerase chain reaction (PCR)

PCR, by Type

Multiplex PCR

Other PCR

PCR, by Product

Instruments

Reagents

Others

In Situ Hybridization (ISH)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Chips and Microarrays

Mass Spectrometry

Transcription Mediated Amplification (TMA)

Others

Competitive Scenario

The following are the main competitors in the global Molecular Diagnostics Market  that are examined in this report along with their capacities and recent developments such as investments, mergers, and acquisitions. The study also includes a SWOT analysis and a complete industry analysis based on Porter's five forces model. It contrasts the strategies employed by different market participants to outperform rivals and boost earnings.

Key Objectives of Market Research Report

The report is stuffed with helpful information, including market trends and business opportunities for the near future.

Recent advances, strategies, and big player shares are present in the competitive environment.

Information on important market segments and sub-segments for keyword, including quantitative, qualitative, value, and volume data.

Data on supply and demand forces and their impacts on the market can be accessed at the regional, sub-regional, and national levels.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Flash Chromatography Market Size

Cystic Fibrosis Market Size

Cancer Biopsy Market Size

Glaucoma Therapeutics Market Size

Genomics Services Market Size

[bhavanameti]

Slide Stainers Market Projected to Reach $5.53 Billion by 2030

Meticulous Research®—a leading global market research company, published a research report titled, ‘Slide Stainers Market by Product (Reagent [Stains, Mounting, Tissue Fixation, Processing] Equipment), Technique (H&E, ISH, IHC, Hematology, Cytology), Application (Diagnosis, Research), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2030.’

According to the latest publication from Meticulous Research®, the slide stainers market is projected to reach $5.53 billion by 2030, growing at a CAGR of 7.9% during the forecast period. This market growth is driven by factors such as the increasing geriatric population, the rising prevalence of chronic diseases, advancements in slide stainer technology, the growing need for personalized treatments, higher healthcare expenditures, the demand for automation in diagnostics and clinical research, and the increasing focus on cancer drug research. Emerging economies and the rising demand for automated slide staining and diagnostic systems also present significant growth opportunities. However, the high cost of slide stainer systems and concerns about automated slide stainers, along with a lack of skilled professionals, pose challenges to market growth.

Key Players

The key players in the slide stainers market include Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Abcam plc. (U.K.), Siemens Healthineers (Germany), General Data Company, Inc. (U.S.), Biocare Medical, LLC. (U.S.), BioGenex (U.S.), PHC Holdings Corporation (Japan), and Hardy Diagnostics (U.S.).

Market Segmentation

The slide stainers market is segmented by:

Product:

Reagents and Kits (including Grossing/Tissue Marking Dyes, Tissue Fixation Reagents, Tissue Processing Reagents, Mounting/Embedding Reagents, Stains [Hematoxylin and Eosin (H&E) Stains, Cytology Stains, Special Stains, Stain Controls, and Other Reagents & Kits])

Equipment (Automated Slide Stainers and Manual Slide Stainers)

Accessories and Consumables

Technique:

Hematoxylin and Eosin (H&E)

In-situ Hybridization (ISH)

Immunohistochemistry (IHC)

Hematology

Cytology

Microbiology

Application:

Disease Diagnosis (Infectious Diseases, Cancer, and Other Diseases)

Medical Research

End User:

Hospitals & Diagnostic Centers

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations (CROs)

Geography:

North America (U.S. and Canada)

Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe)

Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific)

Latin America

Middle East & Africa

In 2023, North America is expected to hold the largest share of the slide stainers market, followed by Europe and Asia-Pacific. The U.S. is projected to be the largest market in North America, driven by its well-developed healthcare infrastructure and the presence of major market players.

Segment Highlights

Product: The reagents & kits segment is expected to dominate the market in 2023 due to the growth in clinical research and development activities and the increasing adoption of laboratory automation solutions.

Technique: The hematoxylin and eosin (H&E) segment is anticipated to hold the largest market share in 2023, favored by its extensive use in examining tissue and cellular structures in research and diagnosis of various diseases.

End User: Hospitals & diagnostic centers are expected to be the largest end-user segment in 2023, driven by the growing patient influx and the need for automated solutions to improve diagnostic efficiency and accuracy.

Geographic Analysis

The report provides an in-depth analysis of major regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to lead the market in 2023, supported by advanced healthcare infrastructure and significant investments in research and development.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5643

Key Questions Addressed in the Report:

Which market segments are expected to experience the highest growth?

What was the historical market size globally?

What are the market forecasts from 2023 to 2030?

What are the key drivers, restraints, opportunities, and challenges?

Who are the major players in the market?

What is the competitive landscape like?

What recent developments have occurred in the market?

What strategies are the leading players adopting?

Which regions/countries are exhibiting high growth?

This comprehensive report provides detailed insights into the slide stainers market, helping stakeholders make informed decisions and capitalize on emerging opportunities.

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research 

[alicesara611]

The Rising Demand for Non-Radioactive Nucleic Acid Labeling Products: A 2030 Outlook

The global non-radioactive nucleic acid labeling product market is expected to grow from US$ 1.5 billion in 2023 to US$ 2.5 billion by 2030, at a CAGR of 7.5% during the forecast period. The growth of the market is attributed to the increasing demand for non-radioactive nucleic acid labeling products in various applications, such as molecular biology, genomics, and proteomics.

Non-radioactive nucleic acid labeling products offer several advantages over radioactive labeling products, such as safety, ease of use, and cost-effectiveness. Radioactive labeling products are hazardous to work with and require specialized training and equipment. Non-radioactive labeling products, on the other hand, are safe to use and do not require any special training or equipment. Additionally, non-radioactive labeling products are typically less expensive than radioactive labeling products.

Request A Sample Copy of This Research Report! https://bit.ly/45QNbgh

Non-radioactive nucleic acid labeling products are a safe and effective alternative to radioactive labeling products. They are used to label nucleic acids, such as DNA and RNA, with a variety of different labels, such as fluorescent dyes, haptens, and enzymes. These labeled nucleic acids can then be used in a variety of different applications, such as in situ hybridization (ISH), Southern blotting, Northern blotting, and Western blotting.

Key Market Trends:

The increasing adoption of non-radioactive labeling techniques in molecular biology and biotechnology research is the key market trend driving the growth of the non-radioactive nucleic acid labeling product market. Non-radioactive labeling techniques are safer, more convenient, and more sensitive than traditional radioactive labeling techniques.

Another key market trend is the growing demand for non-radioactive nucleic acid labeling products in the pharmaceutical industry. Pharmaceutical companies are using non-radioactive labeling products to develop new drugs and therapies.

Key Takeaways:

The global non-radioactive nucleic acid labeling product market is expected to grow from US$ 1.5 billion in 2023 to US$ 2.5 billion by 2030, at a CAGR of 7.5%

The growth of the market is attributed to the increasing demand for non-radioactive nucleic acid labeling products in various life science applications, such as DNA sequencing, PCR, and hybridization.

Other factors driving the market growth include the rising prevalence of infectious diseases, the growing demand for personalized medicine, and the increasing investment in life science research.

Regional Outlook:

North America is expected to be the largest market in terms of revenue, accounting for over 35% of the global market share in 2023.

The growth of the market in this region is attributed to the increasing demand for non-radioactive nucleic acid labeling products in the pharmaceutical and biotechnology industries.

Europe is expected to be the second-largest market, followed by Asia Pacific.

The growth of the market in Asia Pacific is attributed to the increasing investment in life science research and the growing demand for personalized medicine in this region.

Key Players:

Some of the key players in the global non-radioactive nucleic acid labeling product market include:

Thermo Fisher Scientific

PerkinElmer

Roche Diagnostics

GE Healthcare

Illumina

Agilent Technologies

Qiagen

Merck KGaA

Bio Rad Laboratories

Invitrogen

Promega

Segmentation:

By Product Type:

Enzymes

Probes

Kits

Others

By Application:

DNA Sequencing

PCR

Hybridization

Other Applications

By End User:

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Hospitals and Diagnostic Centers

Other End Users

[vaiswr]

In Situ Hybridization Market Size Worth USD 28.86 Billion in 2030

The global in-situ hybridization market size was USD 14.32 Billion in 2021 and is expected to register a revenue CAGR of 8.14% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer, genetic disorders, and infectious diseases is a crucial factor driving market revenue growth.

In-situ hybridization is used for localization of nucleic acids and specific genes in cells, tissues, and histological sections. A reporter molecule, either fluorophore or chromophore, is linked to complementary strand of nucleic acid region of concern to visualize deoxyribonucleic or ribonucleic acids.

[blueweave]

global in situ hybridization (ISH) marketsize at USD 1.42 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global In situ hybridization marketsize to grow at a significant CAGR of 12.73% reaching a value of USD 3.26 billion by 2029. Major growth drivers for the global in situ hybridization market include the rising need for molecular diagnostic tools. The expanding use of ISH is a result of both the rising incidence of chronic diseases and the growing demand for quick diagnostic methods. Technology developments in the IVD (in vitro diagnostics) sector are the other drivers of the ISH market. The development of high value in situ hybridization technologies and the expansion of in situ hybridization use in developing countries like India will provide new market opportunities. However, the in situ hybridization market is anticipated to be hampered by the high cost of probes, FISH's poor ability to detect significant patient abnormalities, and the lengthy detection processes. Also, the development of the global In Situ Hybridization (ISH) market is constrained by the availability of superior technologies, including high-throughput whole genome sequencing, microarray, and others.

Global In situ Hybridization Market – Overview

In situ hybridization (ISH) is a laboratory technique used to detect specific DNA or RNA sequences in cells or tissues. The technique involves the use of a labelled nucleic acid probe that is complementary to the target DNA or RNA sequence. The probe is designed to bind specifically to the target sequence, allowing for its detection and localization within the cells or tissues under study. In situ hybridization can be used to study a wide range of biological phenomena, including gene expression, genetic mutations, chromosomal abnormalities, and viral infections. The technique is widely used in various fields of research, including cancer research, developmental biology, and neuroscience, among others.

Sample Request @ https://www.blueweaveconsulting.com/report/in-situ-hybridization-market/report-sample

[diigo123456]

IHC and IHS Slide Staining Systems Market is expected to offer significant growth at a CAGR of 6.5% during the forecast period 2023-2030 | Biocare Medical, BioGenex Laboratories, Celerus Diagnostics

The market for IHC and IHS (Immunohistochemistry and In Situ Hybridization) slide staining systems is expected to grow because of improvements in healthcare and the introduction of karyotyping and other tools in disease diagnosis. With these devices, automated staining can be done quickly, more efficiently, and with higher quality. This makes each test more productive. The global market for IHC and IHS slide staining systems is divided by type, application, and region. The market is split into four different types: systems, accessories, reagents, and consumables. By use, the immunohistochemistry and in situ hybridization slide staining system market is split into drug manufacturing, pathology research, and disease detection.Estimates and forecasts of the IHC and IHS Slide Staining Systems market size are given in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the years 2017 through 2030, with 2022 as the base year. 

Click Here For A Free Sample PDF Copy Of The IHC and IHS Slide Staining Systems Market Latest Research Before Purchase:

[market-researchm]

Global In Situ Hybridization (ISH) Market Analysis, Share, Growth, Industry Trends, Overview And Forecast To 2025

Global In Situ Hybridization (ISH) Market is expected to reach USD 1.84 billion by 2025. In Situ Hybridization (ISH) is a type of hybridization a method that permits for specific localization of an exact segment of nucleic acid inside a histologic section. That means it involves the use of labeled RNA probes or labeled DNA probes to detect complementary DNA or RNA targets in cytologic preparations or tissue sections. Synthetic oligonucleotides (PNA, LNA), Double-stranded DNA (dsDNA) probes, RNA probes (riboprobes), and Single-stranded DNA (ssDNA) probes are the majorly used ISH probes.

It can be labeled using two major techniques like Non-radioactive labels and radioactive isotopes. A labeled RNA or DNA probe can be used to hybridize to a known target DNA or mRNA sequence within a sample. This labeled RNA or DNA probe can then be detected by using an antibody to detect the label on the probe. The In Situ Hybridization (ISH) industry is estimated to grow at a significant CAGR of 7.3% over the future period as the scope and its applications are rising enormously across the globe. In Situ Hybridization (ISH) Market is segmented based on product type, technology, probe type, application, end use, and region.

Services, instruments, software, and kits & probes are the product types that could be explored in In Situ Hybridization (ISH) in the forecast period. The instruments sector accounted for the largest market share of In Situ Hybridization (ISH) industry and is estimated to continue its dominance in the upcoming years. This may be because of high demand from research laboratories and diagnostic centers. Also, these instruments are easy to handle, cost-efficient, and portable these factors may lead the sector in coming years. However, kits & probes sector is estimated to grow at highest CAGR in the coming years.

Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market/request-sample

The enhanced technology used in In Situ Hybridization (ISH) is Chromogenic In Situ Hybridization (CISH) and Fluorescent In Situ Hybridization (FISH) that could be explored in the future period. RNA probe and DNA probe are the two main types of probes that could be explored in In Situ Hybridization (ISH) in the foremost period. The DNA probes sector is estimated to account largest revenue shares of In Situ Hybridization (ISH) in the coming years. Whereas, RNA sector is estimated to grow at highest CAGR in the coming years.

The market may be categorized based on applications like infectious diseases, cancer, developmental biology, cytogenetics, and others that could be explored in the future period. Cancer sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to grow at highest CAGR in the coming years. The reason could be growing occurrence of cancer and rising research in this sector. However, cytogenetics sector is estimated to grow at fastest pace in the coming years.

End users like academic institutes, research & diagnostic laboratories, contract research organizations (CROs), and others could be explored in In Situ Hybridization (ISH) Market in the forecast period. The research & diagnostic laboratories sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the coming years. This may be because of growing applications of molecular cytogenetics in diagnostics, rising use of enhanced technology in genomics and molecular cytology, and rising initiative in cell research. However, CROs segment is estimated to grow at fastest pace in the coming years.

Globally, North America accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the upcoming years. The reason behind the growth of overall market could be government involvement for development of novel diagnostic tools, availability of research funds, and developed research centers. The United States is a major consumer of In Situ Hybridization (ISH) in this region.

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise, growing awareness regarding advantages of In Situ Hybridization (ISH) technology in diagnostics and government initiative in R&D investments in the field of molecular biology. The developing countries like India and China are the major consumers of In Situ Hybridization (ISH) industry in the region.

The key players of In Situ Hybridization (ISH) Market are Oxford Gene Technology, Thermo Fisher Scientific, Advanced Cell Diagnostics, Inc., Leica BiosystemsNussloch GmbH, NeoGenomics Laboratories, Inc., BIOVIEW, Bio-Rad Laboratories, Inc., Agilent Technologies, PerkinElmer, Inc., and Merck KGaA. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Access Full Research Report @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market

[researchswatistuff]

Tissue Diagnostics Market to be Worth $8.52 Billion by 2029

Meticulous Research®—a leading global market research company, published a research report titled, ‘Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technology (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC, Colorectal, Prostate), End user -Global Forecast to 2029’.

According to this latest publication from Meticulous Research, the global tissue diagnostics market is projected to reach $8.52 billion by 2029, at a CAGR of 7.4%. The rising prevalence of cancer globally, the availability of biomarkers and research on biomarkers, recommendations for cancer screening, the growing number of clinical trials for oncology drugs, and the availability of tissue-based companion diagnostics are the factors driving the growth of this market.                                              

Download Free PDF Sample Copy of the Report (with COVID-19 Impact Analysis):  https://www.meticulousresearch.com/download-sample-report/cp_id=4971

Scope of the Report:

Tissue Diagnostics Market, by Product Type

·         Consumables

o    Antibodies

o    Kits

o    Reagents

·         Instruments

o    Slide Staining Systems

o    Slide Scanners

o    Tissue Processors

o    Other Instruments Note: Other instruments include microarrays and embedding systems.

Tissue Diagnostics Market, by Technology

·         Immunohistochemistry (IHC)

·         In-situ Hybridization (ISH)

·         Digital Pathology

·         H&E Slide Staining

·         Other Technologies Note: Other technologies include molecular, immunofluorescence, and special staining

Tissue Diagnostics Market, by Application

·         Breast Cancer

·         Lung Cancer

·         Colorectal and Gastrointestinal Cancer

·         Prostate Cancer

·         Lymphatic Cancer

·         Other Applications Note: Other applications include cervical cancer, melanoma, lip, oral cavity cancer

Tissue Diagnostics Market, by End User

·         Hospitals and Reference Laboratories

·         Research Institutes

·         Pharmaceutical Companies

·         Contract Research Organization

Tissue Diagnostics Market, by Geography

·         North America 

o    U.S.

o    Canada 

·         Europe 

o    Germany

o    U.K.

o    France

o    Italy

o    Spain

o    Rest of Europe (RoE) 

·         Asia-Pacific (APAC) 

o    China

o    Japan

o    India

o    Rest of APAC (RoAPAC) 

·         Latin America

·         Middle East & Africa

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971

Tissue Diagnostics Market: Future Outlook

The global tissue diagnostics market is segmented by Product Type (Consumables [Antibodies, Kits, Reagents], Instruments [Slide Staining Systems, Slide Scanners, Tissue Processing Systems, Other Instruments {Microarray, Embedding System]), Technology (Immunohistochemistry, In-situ Hybridization, Digital Pathology, H&E Slide Staining, Other Technologies, Application (Breast Cancer, Lung Cancer, Colorectal and Gastrointestinal Cancer, Prostate Cancer, Lymphatic Cancer, Other Applications), End User (Hospitals and Reference Laboratories, Research Institutes, Pharmaceutical Companies, and Contract Research Organization). The study also evaluates industry competitors and analyzes their market shares at the global and regional levels.

Based on product, in 2022, the consumables segment is expected to account for the largest share of the market. The extensive and recurring requirement of consumables and technological advances in developing novel reagents contribute to the large market share of this segment.

Based on technology, the tissue diagnostics market is segmented into immunohistochemistry, in-situ hybridization, digital pathology, H&E staining, and other technologies. In 2022, the immunohistochemistry segment is expected to account for the largest share of the global tissue diagnostics market. Developments in in-vitro diagnostics and the upsurge in point-of-care diagnostics are the factors contributing to the growth of this segment.

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=4971

Based on application, the tissue diagnostics market is segmented into breast cancer, lung cancer, colorectal and gastrointestinal cancer, prostate cancer, lymphatic cancer, and other applications. In 2022, the breast cancer segment is expected to account for the largest share of the global tissue diagnostics market. The growth of this segment is attributed to the high prevalence of breast cancer and the presence of several research and screening programs for combating breast cancer.

Based on end user, in 2022, the hospital and reference laboratories segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high inflow of patients and tests due to the increasing prevalence of cancer.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2022, North America is expected to account for the largest share of the tissue diagnostics market. The large market share of this regional market is driven by the high cancer prevalence, easy accessibility to advanced technologies, and the presence of public programs for cancer management.

The key players operating in the global tissue diagnostics market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Sigma-Aldrich Co. LLC) (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Abcam plc (U.K.), Becton, Dickinson, and Company (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Bio-Genex Laboratories, Inc. (U.S.), Bio SB, INC (U.S.), 3DHISTECH Ltd. (Hungary), and HOLOGIC, INC. (U.S.)

Key questions answered in the report-

·  Which are the high-growth market segments in terms of product type, technology, application, end user, and regions/countries?

·  What was the historical market for tissue diagnostics across the globe?

·  What are the market forecasts and estimates for the period 2022–2029?

·  What are the major drivers, restraints, challenges, opportunities, and trends in the global tissue diagnostics market?

·  Who are the major players in the global tissue diagnostics market?

·  How is the competitive landscape, and who are the market leaders in the global tissue diagnostics market?

·  What are the recent developments in the tissue diagnostics market?

·  What are the different strategies adopted by the major players in the tissue diagnostics market?

·  What are the geographical trends and high-growth regions/countries?

You can Buy Report from Here: https://www.meticulousresearch.com/Checkout/27604669

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[globalmarketsresearchreports]

Global Tissue Diagnostic Market Highlights and Forecasts to 2031

Tissue Diagnostic Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

TBRC’s market report includes a chapter on the COVID-19 impact on the tissue diagnostic industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected tissue diagnostic market growth numbers from 2022-2031.

Request a Sample of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=6505&type=smp

The global tissue diagnostic market size is expected to grow from $4.27 billion in 2021 to $4.56 billion in 2022 at a compound annual growth rate (CAGR) of 6.84%. The global tissue diagnostics market share is expected to grow to $5.99 billion in 2026 at a CAGR of 7.05%.

View more on the report:

The Tissue Diagnostic Global Market Report 2022-31 by The Business Research Company evaluates tissue diagnostic market size, growth rate, drivers, tissue diagnostic industry trends, and major companies.

The tissue diagnostic market segments in the report are:

1) By Product: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing System

2) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, Special Staining

3) By Disease: Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)

4) By End-User: Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations

The table of contents in TBRC’s tissue diagnostic market report includes:

1. Executive Summary

2. Market Characteristics

3. Market Trends And Strategies

4. Impact Of COVID-19

5. Market Size And Growth

6. Segmentation

7. Regional And Country Analysis

.

.

.

27. Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

About The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 28+ countries globally.  

Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Contact Information:  The Business Research Company  Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Blog: http://blog.tbrc.info/

[prajwal-agale001]

Slide Stainers Market Trends: Technological Advancements Driving Growth

According to a recent publication by Meticulous Research®, the global slide stainers market is anticipated to grow significantly, reaching a valuation of $5.53 billion by 2030 with a compound annual growth rate (CAGR) of 7.9% during the forecast period. The market's expansion is largely driven by several key factors, including the rising geriatric population, an increasing burden of chronic diseases, technological advancements in slide stainers, and the growing need for personalized treatments. Moreover, the surge in healthcare expenditure and the growing demand for automation in diagnostics and clinical research are playing pivotal roles in propelling the market forward. The increasing focus on cancer drug research and development, coupled with opportunities in emerging economies, is also expected to contribute to the market's growth trajectory.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5643

However, certain challenges may hinder the market's growth. The high cost associated with slide stainer systems remains a significant restraint. Additionally, concerns regarding the reliability and performance of automated slide stainers, coupled with a shortage of skilled professionals, present notable obstacles that could potentially slow down market expansion.

Product Segmentation Insights

The slide stainers market is categorized into three main segments based on product type: reagents & kits, equipment, and accessories & consumables. Among these, the reagents & kits segment is expected to dominate the market in 2024. This segment's prominence is attributed to the essential role that slide staining reagents and kits play in identifying specific tissue types and abnormalities. The increasing adoption of laboratory automation solutions and the growth in clinical research and development activities are key factors driving the demand for reagents and kits.

Technique-Based Analysis

Based on technique, the market is segmented into hematoxylin and eosin (H&E), in-situ hybridization (ISH), immunohistochemistry (IHC), hematology, cytology, and microbiology. The hematoxylin and eosin (H&E) technique is expected to hold the largest market share in 2024. This technique is favored by pathologists for its ability to provide detailed insights into tissue and cellular structures, making it an invaluable tool for diagnosing a range of conditions, including cancer and infectious diseases.

End User Segment Overview

The end-user segment of the slide stainers market includes hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). Hospitals and diagnostic centers are anticipated to be the largest contributors to the market in 2024. The growing demand for automated slide stainer systems in these settings, which are essential for preparing slides for microscopic examination, is a key driver of this segment's growth. Additionally, the increasing patient flow in hospitals due to the rising incidence of infectious diseases and the need for efficient diagnostic processes further bolster this segment.

Regional Market Dynamics

Geographically, the slide stainers market is analyzed across several major regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2024, North America is expected to dominate the market, with the U.S. being the largest contributor within the region. The significant market share in North America is attributed to the region's highly developed healthcare infrastructure and the presence of leading market players such as Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), and Agilent Technologies, Inc. (U.S.).

Key Market Players

Prominent players in the slide stainers market include Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Abcam plc. (U.K.), Siemens Healthineers (Germany), General Data Company, Inc. (U.S.), Biocare Medical, LLC. (U.S.), BioGenex (U.S.), PHC Holdings Corporation (Japan), and Hardy Diagnostics (U.S.).

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research 

[industry-reports-data]

Companion Diagnostics Market Share, Size Global Regional Analysis, Key Findings,Industry Demand, Key Players and Forecasts to 2027

Companion Diagnostics Market research report covers inclusive data on prevalent trends, drivers, growth opportunities, and restraints that can variation the market changing aspects of the global industry. This report provides an in-depth analysis of the market segmentation that contains products, applications, and geographical analysis. Global Companion Diagnostics market report delivers a close watch on leading participants with strategic analysis, micro and macro market trend and scenarios, pricing analysis, and a complete overview of the industry conditions during the forecast period.

Report Coverage:

The research report of the defending coatings industry offers a inclusive analysis of existing companies that can affect the market outlook throughout the forthcoming years. In addition to that, it affords an accurate assessment by highlighting data on multiple aspects that may contain growth drivers, opportunities, trends, and hindrances. It also represents the overall: Companion Diagnostics market size from a global perception by analysing historical data and qualitative insights.

Companion Diagnostics Market is envisaged to record an expansion at the CAGR of 20.5% over the forecast period, 2022 – 2027.

Strong expertise with attention to detail makes our market research reports stand apart, Request a Report Sample PDF here:

Major Players Operating in the: Companion Diagnostics Market:

Tocagen, Takeda Pharmaceutical Co Ltd (TYO: 4502), Siemens Healthineers (ETR: SHL), Abbott Laboratories (NYSE: ABT), QIAGEN N.V. (NYSE: QGEN), Roche Diagnostics, Thermo Fisher Scientific Inc., Covance, Myriad Genetics Inc. (NASDAQ: MYGN), Agilent Technologies (NYSE: A), Illumina (NASDAQ: ILMN)

Companion Diagnostics Market Analysis:

The Companion Diagnostics market research report provides an in-depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. The segmentation chapters enable readers to understand aspects of the market such as its products, market size, manufacturer details, share, available technology, and applications. The research report also provides detailed information on new trends that may define the development of these segments in the coming years.

On the basis of types, the: Companion Diagnostics market is primarily split into

Polymerase Chain Reaction Test (PCR)

Immunohistochemistry Test (IHC)

In Situ Hybridization Test (ISH)

Others

On the basis of applications, the: Companion Diagnostics market covers:

Lung Cancer

Breast Cancer

Colorectal Cancer

Leukemia

Melanoma

Others

For More Information or Query or Customization Before Buying, Visit @

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in Companion Diagnostics market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in Companion Diagnostics market.

Considering the Geographical Landscape of Companion Diagnostics market:

Companion Diagnostics Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities.

➤ North America (United States, Canada, and Mexico)

➤ Europe (UK, Germany, France, Russia, and Italy)

➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)

➤ South America (Brazil, Colombia, Argentina, etc.)

➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)

Research Methodology:

This report offers actionable growth insights and an extensive report comprising secondary research, primary interviews with industry stakeholders, competitors, validation, and triangulation with the Worldwide Market Reports regional database. Experts have detailed primary records with the market players across the value chain in all regions and industry experts to obtain qualitative and quantitative insights.

Key Benefits for: Companion Diagnostics Market Reports:

✦ What is the global sales value, production value, consumption value, import, and export of industry?

✦ Who are the global key manufacturers of Companion Diagnostics industry? What is their operating situation?

✦ What are Companion Diagnostics market opportunities and threats faced by the vendors in the global Companion Diagnostics Industry?

✦ Which application/end-user or product type may seek incremental growth prospects?

✦ What focused approach and constraints are holding the market?

✦ What are the different sales, marketing, and distribution channels in the global industry?

About Us:

IndustryDataAnalytics is your single point market research source for all industries including pharmaceutical, chemicals and materials, energy resources, automobile, IT, technology and media, food and beverages, and consumer goods, among others.

We will get in touch with you within 24hrs and help you find the research reports and Additional Customization you need

Head of Sales: Mr. Hon Irfan Tamboli

 +1 (704) 266-3234 | contact@industrydataanalytics.com

[vaiswr]

In-Situ Hybridization Market Analysis By Industry Share, New Investment Opportunities, and Forecast till 2030

The global in-situ hybridization market size was USD 14.32 Billion in 2021 and is expected to register a revenue CAGR of 8.14% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer, genetic disorders, and infectious diseases is a crucial factor driving market revenue growth.

In-situ hybridization is used for localization of nucleic acids and specific genes in cells, tissues, and histological sections. A reporter molecule, either fluorophore or chromophore, is linked to complementary strand of nucleic acid region of concern to visualize deoxyribonucleic or ribonucleic acids. It is extensively used for assessing degree of gene expression, evaluate production of different proteins that may lead to diseases, and also diagnose pathogenic diseases based on complementary molecules of bacterial and viral genomes. In addition, applications of in-situ hybridization in karyotyping, phylogenetic analysis, physical mapping, developmental biology and pathology profiling have increased its adoption in various end-use industries and research sectors. This is expected to significantly contribute to revenue growth of the in-situ hybridization market between 2022 and 2030.

[emergenresearch1]

The global in-situ hybridization market size reached USD 905.3 Million in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer, genetic disorders, and infectious diseases is expected to drive revenue growth of the global in-situ hybridization market during the forecast period.